Open reduction and internal fixation versus percutaneous multiple-trajectory screw fixation for unstable pelvic fractures with severe polytrauma: a prospective study

开放复位内固定术与经皮多轨迹螺钉固定术治疗伴有严重多发伤的不稳定骨盆骨折:一项前瞻性研究

阅读:1

Abstract

OBJECTIVE: To compare the clinical outcomes of open reduction and internal fixation (ORIF) versus percutaneous multiple-trajectory screw fixation (PMSF) in the treatment of unstable pelvic fractures with severe polytrauma, and to provide a basis for optimizing surgical strategies. METHODS: A prospective study included 26 patients (January-July 2024) divided into ORIF (n = 15) and PMSF (n = 11) groups. ORIF used traditional open plating/screws, while PMSF employed fluoroscopy-guided minimally invasive screws. Primary outcomes: operative time, blood loss, complications (infection, nerve injury), fracture reduction (Matta criteria), functional recovery (Majeed score). Secondary outcomes: hospital stay, preoperative waiting time. Age, ISS, and Tile classification were controlled. SPSS 27.0 analyzed data (significance P < 0.05). RESULTS: The PMSF group demonstrated significantly shorter preoperative waiting times (124.09 ± 54.45 h vs. 260.67 ± 170.92 h, P = 0.018), less intraoperative blood loss (68.18 ± 49.96 mL vs. 510.00 ± 264.71 mL, P < 0.001), and shorter hospital stays (23.36 ± 8.64 days vs. 33.93 ± 12.54 days, P = 0.024) compared with the ORIF group. There were no significant differences in the rates of excellent/good fracture reduction (Matta criteria: PMSF 90.91% vs. ORIF 86.67%, P = 1.000) or 12-month Majeed scores (82.73 ± 7.89 vs. 75.40 ± 13.64, P = 0.125) between the two groups. CONCLUSION: For patients with unstable pelvic fractures with severe polytrauma, PMSF offers a better minimally invasive treatment option over traditional ORIF in terms of reducing trauma and shortening rehabilitation periods, while achieving comparable fracture reduction quality and functional recovery. Therefore, PMSF can be considered a preferred choice for such cases. TRIAL REGISTRATION: This study was retrospectively registered. Chinese Clinical Trial Registry (ChiCTR2500110578; Registration date: 16/10/2025;PID:288327). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12893-026-03493-z.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。